The study included 36292 consecutive patients undergoing acute myocardial infarction receiving PCI with the new generation stent SYNERGY (thin struts, bioresorbable polymer and everolimus eluting); 39.7% presented ST elevation MI.
Kaplan-Meier curves at 2 years of patients receiving the SYNERGY vs patients receiving other drug eluting stents resulted very similar for thrombosis (0,69% vs 0,81%, p=0.99) or clinically relevant restenosis (1,48% vs 1,25%; p=0.72).
No clinical differences, such as infarction or death, were observed between devices.
Read also: LeDRA: Left Distal Radial Approach for angiography and angioplasty.
In this cohort of unselected patients undergoing acute MI, revascularization with SYNERGY DES had the same results as other DES available in the market.
Original title: Bioabsorbable polymer everolimus-eluting stents in patients with acute myocardial infarction: a report from the Swedish Coronary Angiography and Angioplasty Registry.
Presenter: Sergio Buccheri.
Get the latest scientific articles on interventional cardiologySubscribe to our weekly newsletter
We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.
